AI-CVD vs Stethee Pro 1

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 60/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
by HeartLung AI
VS
by M3DICINE

AI Verdict

AI-CVD specializes in opportunistic screening for cardiovascular and multisystem diseases by analyzing existing CT scans, providing insights from radiological imaging. In contrast, Stethee Pro 1 is an AI-enabled wireless digital stethoscope system designed for real-time cardiac and respiratory vital sign analysis through auscultation. While both leverage AI in cardiology and pulmonology, they address different points in the diagnostic workflow and utilize distinct data acquisition methods.

Choose AI-CVD if…

Choose AI-CVD if your primary goal is to leverage existing CT scan data for opportunistic screening and early detection of cardiovascular and multisystem diseases. This tool is ideal for identifying hidden health risks without requiring additional imaging, radiation, or workflow disruption, making it suitable for retrospective analysis or proactive risk assessment from routine scans.

View AI-CVD →

Choose Stethee Pro 1 if…

Choose Stethee Pro 1 if you require real-time, AI-enabled cardiac and respiratory vital sign analysis at the point of care or for remote patient monitoring. This wireless digital stethoscope system is best suited for immediate diagnostic insights, advanced sound amplification, and secure data sharing in telemedicine or clinical settings where active patient examination is crucial.

View Stethee Pro 1 →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature AI-CVD Stethee Pro 1
Pricing Unknown $499 usd
Deployment Unknown Cloud, Mobile
BAA Available Yes AI-estimated Unknown
FDA Status Cleared AI-estimated Cleared AI-estimated
HIPAA Yes AI-estimated Yes AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

AI-CVD

AI-CVD integrates seamlessly into existing CT scan workflows, performing opportunistic screening without requiring additional imaging, radiation, contrast, or workflow disruption. This passive integration minimizes user burden and learning curves. Stethee Pro 1, while offering advanced features, requires active use of a physical device, mobile app, and web portal, implying a more direct user interaction and potential workflow adjustments.

Clinical Value

AI-CVD

AI-CVD offers FDA-cleared opportunistic screening for a broad range of cardiovascular and multisystem diseases using existing CT scans, enabling early detection of hidden risks like CAC scoring and cardiac chamber volumetry. This proactive identification of conditions from already acquired data provides significant potential for early intervention. Stethee Pro 1 enhances real-time diagnostics and telemedicine, but AI-CVD's ability to uncover previously undetected conditions from existing data offers a distinct advantage in population health.

Pricing & Value

Stethee Pro 1

Stethee Pro 1 provides transparent upfront pricing for its device ($499), offering a clear initial understanding of the investment, even though the subscription cost for the web portal is not specified. AI-CVD's pricing is not publicly available and requires direct contact with the vendor, making it less transparent for potential buyers.

Enterprise Readiness

AI-CVD

AI-CVD is FDA-cleared, cloud-deployed, and specifically designed for opportunistic screening using existing CT scans, which implies seamless integration into large-scale radiology workflows with minimal disruption. Its claim of 'no workflow disruption' is a strong indicator of enterprise readiness. Stethee Pro 1, while also FDA-cleared and HIPAA compliant, involves deploying physical devices and managing mobile applications, which can present different integration and management challenges within an enterprise.

Innovation

AI-CVD

AI-CVD innovates by leveraging existing CT scans to perform opportunistic screening for multiple cardiovascular and multisystem diseases, extracting new diagnostic value from already acquired data without additional patient burden. This approach is highly innovative for proactive health management and resource optimization. Stethee Pro 1 innovates by transforming the traditional stethoscope with AI, wireless capabilities, and environmental data, but AI-CVD's method of deriving new insights from existing data for broad screening is arguably more groundbreaking in its application.

Support & Docs

Stethee Pro 1

M3DICINE, the company behind Stethee Pro 1, provides more accessible and structured support resources, including a dedicated support section on its website with FAQs and contact options. In contrast, specific support or documentation details for AI-CVD are not readily available in the provided facts or through general web searches.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature AI-CVD Stethee Pro 1
Name AI-CVD Stethee Pro 1
Company HeartLung Corporation M3DICINE Pty Ltd.
Description FDA-cleared, AI-powered quantitative imaging platform that performs opportunistic screening for cardiovascular and multisystem diseases using existing CT scans, enabling early detection of hidden health risks. FDA-cleared, AI-enabled wireless digital stethoscope system providing real-time cardiac and respiratory vital sign analysis, advanced amplification, and secure data sharing for enhanced diagnostics and telemedicine.
Categories Cardiology AI Cardiology AI, Wearables & Remote Monitoring (RPM)
Specialties Cardiology, Pulmonology, Radiology Cardiology, Emergency Medicine, Pulmonology
Key Features Automated CT-derived anatomical and density-based measurements; Opportunistic screening from existing chest and abdominal CT scans; No additional imaging, radiation, contrast, or workflow disruption; Coronary Artery Calcium (CAC) scoring; Aortic wall, aortic valve, and mitral valve calcium analysis; Cardiac chamber volumetry (Left Atrium, Left Ventricle, Right Atrium, Right Ventricle); Epicardial fat volumetry; Aorta and pulmonary artery sizing AI-enabled wireless digital stethoscope system; Captures cardiac and respiratory vital signs in 20 seconds; Measures systole, diastole, heart cycle durations, and respiration rate; Sophisticated sound amplification (up to 96x) and 5 proprietary digital filters; Real-time visualization of heart (PCG, AIDA Cycle, AIDA Energy) and lung sounds (spectrogram); Mobile app (iOS and Android) and HIPAA compliant Central Web Portal; Secure data capture, analysis, recording, playback, and sharing capabilities; Automatic geo-location and environmental data tagging (humidity, temperature, pollen count, pollution)

Videos

Demos, reviews, and walkthroughs featuring AI-CVD and Stethee Pro 1.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

AI-CVD is an AI-powered quantitative imaging platform that performs opportunistic screening by analyzing existing CT scans, requiring no new patient interaction or imaging. In contrast, Stethee Pro 1 is an AI-enabled wireless digital stethoscope system that actively captures real-time cardiac and respiratory vital signs and sounds during a physical examination.
AI-CVD provides automated CT-derived measurements for coronary artery calcium scoring, aortic/mitral valve calcium analysis, cardiac chamber volumetry, and epicardial fat volumetry, enabling early detection of hidden risks. Stethee Pro 1 offers real-time analysis of heart and lung sounds, measures vital signs like systole, diastole, heart cycle durations, and respiration rate, and provides sophisticated sound amplification for enhanced diagnostics and telemedicine.
AI-CVD is designed for opportunistic screening using existing CT scans, meaning it requires no additional imaging, radiation, contrast, or workflow disruption. Stethee Pro 1 integrates as a digital stethoscope system, requiring direct patient interaction to capture vital signs and sounds, enhancing the physical examination and telemedicine capabilities.
AI-CVD is primarily for Cardiology, Pulmonology, and Radiology, focusing on imaging-based screening. Stethee Pro 1 is for Cardiology, Emergency Medicine, and Pulmonology, focusing on real-time auscultation and vital sign analysis. Both tools share applications in Cardiology and Pulmonology but approach diagnostics from different modalities.
AI Tool Finder
AI-powered search. Results may not be comprehensive.